TP53 and neuroblastoma: Although RNAi-mediated p53 depletion decreases neuroblastoma cell sensitivity to YM155 as previously demonstrated [10], only 4 out of 14 nutlin-3-adapted TP53-mutant neuroblastoma cell lines displayed a >2-fold increased YM155 IC50 relative to the respective parental cell line.